Ian T Meredith Boston Scientific Corp (BSX) insider trading activity

Ian T Meredith is EVP Global Chief Med Officer of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 28,082 shares of BSX, which is worth approximately $2.51 Million. The most recent transaction as insider was on Mar 28, 2022, when has been sold 6,588 shares (Common Stock) at a price of $43.68 per share, resulting in proceeds of $287,764. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.1K

0% 3M change

0% 12M change

Total Value Held $2.51 Million

Ian T Meredith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 28 2022	SELL Open market or private sale	$287,764 $43.68 p/Share	6,588 Reduced 19.0%	28,082 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$13,251 $44.17 p/Share	300 Reduced 0.86%	34,670 Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	-	1,019 Added 2.83%	34,970 Common Stock
Feb 21 2022	SELL Payment of exercise price or tax liability	$12,680 $42.55 p/Share	298 Reduced 0.87%	33,951 Common Stock
Feb 21 2022	BUY Exercise of conversion of derivative security	-	1,013 Added 2.87%	34,249 Common Stock
Feb 18 2022	SELL Payment of exercise price or tax liability	$12,978 $42.55 p/Share	305 Reduced 0.91%	33,236 Common Stock
Feb 18 2022	BUY Exercise of conversion of derivative security	-	1,037 Added 3.0%	33,541 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$15,719 $42.83 p/Share	367 Reduced 1.12%	32,504 Common Stock
Feb 17 2022	BUY Exercise of conversion of derivative security	-	1,250 Added 3.66%	32,871 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$14,347 $44.01 p/Share	326 Reduced 1.02%	31,621 Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	-	1,108 Added 3.35%	31,947 Common Stock
Feb 01 2022	SELL Payment of exercise price or tax liability	$39,976 $43.5 p/Share	919 Reduced 2.89%	30,839 Common Stock
Feb 01 2022	BUY Exercise of conversion of derivative security	-	3,131 Added 8.97%	31,758 Common Stock
Jan 01 2022	SELL Payment of exercise price or tax liability	$53,737 $42.48 p/Share	1,265 Reduced 4.23%	28,627 Common Stock
Jan 01 2022	BUY Exercise of conversion of derivative security	-	3,649 Added 10.88%	29,892 Common Stock
Dec 28 2021	SELL Open market or private sale	$303,248 $43.21 p/Share	7,018 Reduced 21.1%	26,243 Common Stock
Feb 28 2021	SELL Payment of exercise price or tax liability	$11,595 $38.78 p/Share	299 Reduced 0.91%	32,553 Common Stock
Feb 28 2021	BUY Exercise of conversion of derivative security	-	1,018 Added 3.01%	32,852 Common Stock
Feb 21 2021	SELL Payment of exercise price or tax liability	$11,333 $38.03 p/Share	298 Reduced 0.93%	31,834 Common Stock
Feb 21 2021	BUY Exercise of conversion of derivative security	-	1,012 Added 3.05%	32,132 Common Stock
Feb 18 2021	SELL Payment of exercise price or tax liability	$11,444 $37.52 p/Share	305 Reduced 0.97%	31,120 Common Stock
Feb 18 2021	BUY Exercise of conversion of derivative security	-	1,037 Added 3.19%	31,425 Common Stock
Feb 15 2021	SELL Payment of exercise price or tax liability	$12,477 $38.39 p/Share	325 Reduced 1.06%	30,388 Common Stock
Feb 15 2021	BUY Exercise of conversion of derivative security	-	1,107 Added 3.48%	30,713 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$49,262 $38.85 p/Share	1,268 Reduced 4.11%	29,606 Common Stock

ITM

Ian T Meredith

EVP Global Chief Med Officer

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account